Diabetologie und Stoffwechsel 2017; 12(S 01): S1-S84
DOI: 10.1055/s-0037-1601674
Poster: *Poster + Kurzpräsentation
Adipositas
Georg Thieme Verlag KG Stuttgart · New York

Structured patient education SlimDate® vs. body-shaping procedures in weight management in metabolic syndrome: retrospective real-life data analysis

K Howorka
1   Medizinische Universtität Wien, Zentrum f Medizinische Physik und Biomed. Technik, Wien, Austria
,
D Duric
2   Forschungsgruppe Funktionelle Rehabilitation und Gruppenschulung, Wien, Austria
,
J Pumprla
3   Clinic Swiss, Esthetics Dept., Olomouc, Czech Republic
,
E Howorka
2   Forschungsgruppe Funktionelle Rehabilitation und Gruppenschulung, Wien, Austria
,
E Perneczky
2   Forschungsgruppe Funktionelle Rehabilitation und Gruppenschulung, Wien, Austria
› Author Affiliations
Further Information

Publication History

Publication Date:
05 May 2017 (online)

Also available at
 

Aim:

Whether metabolic syndrome management in outpatient setting benefits from a wider spectrum of non-invasive body-shaping methods was investigated in a retrospective bi-centric analysis considering short- and long-term effects of the most popular fat-targeting add-on procedures.

Patients and methods:

In a self-selected group of n = 216 informed patients with diabetes or metabolic syndrome (insulin n = 122, type 1 diabetes n = 66, females 75%, age 52.5 ± 13.2yrs, BMI 28.8 ± 4.4 kg/m2, abdominal circumference 99.7 ± 13.1 cm), several fat targeting interventions have been freely chosen additionally to a consistently offered standardized group education (n = 127, module SlimDate® n = 104, Curriculum FIT, Kirchheim Publishers, 2009). Their comparative efficacy was evaluated by means of ANOVA. Bioimpedance body composition analysis and calliper skin fold assessment have been routinely used.

Results:

Short-term results revealed higher impact on weight/BMI of interventions including food restriction (deltas of weight and abdominal circumference; *p < 0.05 and **p < 0.01 for short-term effects): Radiofrequency/Vanquish® n = 31 (-2.0 ± 1.7 kg**, 4.3 ± 1.7 cm**); Radiofrequency/Exilis® n = 21 (-1.5 ± 3.0 kg*, -2.8 ± 3.0 cm**); Injection lipolysis (phosphatidylcholine, off-label) n = 14 (-2.3 ± 1.9 kg*, -4.5 ± 2.1 cm**); Cold-induced Thermogenesis/SlimVest® n = 12 (0.0 kg (Q1 =-1.1; Q3 = 0.8); -0.7 cm (Q1 =-2.8; Q3 = 1.5); Very Low Calorie Diet VLCD/MyLine® n = 21 (-5.2 ± 3.7 kg**, -4.9 ± 2.9 cm**), VLCD with off-label ß-HCG after Simeons® (off-label) n = 14 (-7.0 ± 2.9 kg**, -6.0 ± 2.5 cm**). SlimDate® n = 104 (weight loss short term: -1 kg (-4;0), p < 0.05, long- term follow-up = 7yrs: no weight gain; p = 0.9). Long-term follow-up for other add-on interventions displayed stronger effects for VLCD-based interventions (p < 0.05 ANOVA).

Conclusions:

Procedures not including any relevant caloric restriction like radiofrequency or cold-induced thermogenesis as used under real-life conditions of a specialized diabetes outpatient office showed limited and mainly aesthetic effectiveness. SlimDate® results in no weight gain up to 7yrs.